CAMP4 Therapeutics Corporation — Quarterly Cash Flow (NASDAQ:CAMP) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Total assets 78.31 M62.77 M51.27 M86.39 M117.81 M Total liabilities 15.16 M11.2 M11.29 M27.73 M70.1 M Total equity 63.14 M51.57 M39.99 M58.67 M47.7 M Total liabilities & shareholders' equities 78.31 M62.77 M51.27 M86.39 M117.81 M Total debt ————— Net debt —————

뉴스

Camp4 Therapeutics: Strong Cash Runway As CMP-002 Moves Toward Human Trials (NASDAQ:CAMP)

Cantor Fitzgerald reiterates Overweight on CAMP4 stock, $7 target

Camp4 Therapeutics Corporation (CAMP) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's Why

Camp4 테라퓨틱스, 워터타운 임대 계약 체결 및 케임브리지 철수 가속화

Camp4 Therapeutics signs new Watertown lease, accelerates Cambridge exit

GSK Deal Is Key Validation For CAMP4's Drug Discovery Platform: Analyst - Camp4 Therapeutics (NASDAQ:CAMP), GSK (NYSE:GSK)

Camp4 테라퓨틱스, 3천만 달러 규모 주식 공모에 하락세

Camp4 Therapeutics stock falls after pricing $30 million share offering

캠프4, 3천만 달러 규모의 주식 공모 가격 결정

CAMP4 Therapeutics prices $30 million common stock offering

CAMP4 Therapeutics and GSK partner on ASO development for diseases